Options
Intranasal rapamycin ameliorates Alzheimer-like cognitive decline in a mouse model of Down syndrome
Fecha de emisión
2018
Autor(es)
Tramutola A.
Lanzillotta C.
Barone E.
Arena A.
Zuliani I.
Mosca L.
Blarzino C.
Butterfield D.A.
Perluigi M.
Di Domenico F.
DOI
10.1186/s40035-018-0133-9
Temas
Alzheimer disease
APP
Autophagy
Down syndrome
mTOR
Oxidative stress
Rapamycin
Tau
amyloid precursor pro...
rapamycin
tau protein
Alzheimer disease
animal experiment
animal model
Article
autophagy
cognitive defect
controlled study
dose response
Down syndrome
drug effect
drug efficacy
female
hippocampus
insulin signaling
male
metabolite
mouse
mTOR signaling
neuroprotection
nonhuman
novel object recognit...
oxidative stress
priority journal
protein homeostasis
protein phosphorylati...
radial arm maze test
single drug dose
treatment outcome
Archivo(s)